Effective adverse event reduction with bolus-basal versus sliding scale insulin therapy in patients with diabetes during conventional hospitalization: Systematic review and meta-analysis

Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición
Covadonga Gómez CuervoJuan Vila Santos

Abstract

The aim of this review was to assess the effectiveness to reduce clinical adverse events and safety of insulin administered in basal-bolus-corrector or basal-corrector regimens (BB) versus a sliding scale scheme (SS) in patients with diabetes or newly diagnosed hyperglycemia admitted to a conventional (not critical) medical or surgical hospital ward. A Medline search was conducted. The Odds ratio was the main summary measure. A random effects model with the Mantel-Haenszel procedure was used. A total of 957 citations were collected, of which nine were finally included in the systematic review. Patients in the BB group had better blood glucose control than those with SS. Overall, there was a nonsignificant trend to a lower risk of adverse events in the BB as compared to the SS group (OR 0.67 [95% CI 0.22 to 2.04], [I(2)=71%]). There was a nonsignificant trend to an increased risk of hypoglycemia in the BB group (OR 2.29 [95% CI 0.50 to 10.49] [I(2)=70%]). Despite its benefit for glycemic control during hospitalization, this review did not show that use of the BB scheme decreases clinical events in patients hospitalized in a conventional ward. Because of heterogeneity of the results, we think that clinical trials are needed addre...Continue Reading

References

Apr 7, 1998·JPEN. Journal of Parenteral and Enteral Nutrition·J J PomposelliB R Bistrian
Mar 13, 2002·The Journal of Clinical Endocrinology and Metabolism·Guillermo E UmpierrezAbbas E Kitabchi
Aug 11, 2005·The Annals of Pharmacotherapy·J Megan SchoefflerDouglas G Gresham
Aug 30, 2007·Diabetes Care·Abbas E Kitabchi, Ebenezer Nyenwe
Apr 16, 2009·JAMA : the Journal of the American Medical Association·Mikhail KosiborodJohn A Spertus
Jul 1, 2009·Diabetes Care·Alexander TurchinMerri L Pendergrass
Oct 15, 2009·The Annals of Pharmacotherapy·Gita Wasan PatelEvangelina Casteneda
Feb 16, 2011·Annals of Internal Medicine·Devan KansagaraMark Helfand
Oct 25, 2011·The American Journal of Medicine·Laura BoucaiJoel Zonszein
Nov 15, 2011·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Marta BotellaJulia Alvarez
Nov 18, 2011·The Journal of Clinical Endocrinology and Metabolism·Mohammad Hassan MuradVictor M Montori
Nov 19, 2011·BMJ : British Medical Journal·Srinivasa Vittal KatikireddiSally Macintyre
Mar 14, 2012·The Medical Journal of Australia·Greg W RobertsStephen N Stranks
Oct 25, 2012·The American Journal of Cardiology·Joel Papak, Devan Kansagara
Jan 23, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Aidar R GosmanovGuillermo E Umpierrez
Jan 25, 2014·Diabetes Research and Clinical Practice·Yoojin KimSirimon Reutrakul
May 13, 2014·Journal of Diabetes and Its Complications·Guillermo E Umpierrez, Mikhail Kosiborod

❮ Previous
Next ❯

Citations

Nov 30, 2018·The Cochrane Database of Systematic Reviews·Luis Enrique Colunga-LozanoCarlos A Cuello-García

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.